Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2013 FY- Text added to 2014 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
addressed, adult, Antibody, attack, belief, binimetinib, biopharmaceutical, boundary, Brain, broader, BURKE, Carlo, cGMP, chaperone, Chapter, checkpoint, CMS, cobrim, colorectal, COMETRQ, Cosmetic, counterfeit, creation, cyber, dabrafenib, DEBORAH, deprioritized, diabetic, doubt, ecorafenib, Engineered, expiry, fifteen, forecast, forum, futility, GCP, genitourinary, hacker, harder, Heat, heavily, HESSEKIEL, immature, immune, immunotherapy, inclusive, ipilimumab, ipilumumab, IRC, IV, Japanese, JEFFREY, lapse, leadership, Lee, Likewise, Lymph, malfeasance, mCRPC, men, Mirati, Moffitt, molecularly, Monte, mRCC, Neoadjuvant, nephropathy, neuroendocrine, nivolimab, nivolumab, Node, Norway, Obama, ORR, OS, Paclitaxel, Palpable, pancreatic, payer, pembrolizumab, percent, persistent, pharmacodynamic, platinum, predominantly, pretreated, prevalent, prognostic, proliferation, prosecutorial, protein, ramp, regression, relief, relieve, rental, revaluation, Russia, saving, Shock, simulation, sophistication, stolen, subgroup, switch, Switzerland, tasked, Taxpayer, tracing, trametinib, trillion, triple, Turkey, unsolicited, vacant, verification, Zelboraf
Removed:
abroad, acting, affecting, afford, Affordability, Algeta, alpharadin, alter, assert, assign, attained, authorize, background, baseline, Biotech, blinding, capability, capacity, carryover, cohort, collected, Cologne, conclusion, concomitant, conflicting, constantly, context, curtail, deconsolidation, decrement, depending, differentiate, diminishing, discontinue, dosed, drew, environment, essential, ethically, evolution, exploring, floor, German, Germany, halt, illustrate, inclined, inflow, installment, intensity, Kingdom, light, LLC, managing, mediated, misappropriate, mitoxantrone, modest, NRE, obligating, opioid, partnership, pertaining, practically, precise, proceed, purpose, qualitative, raf, recall, remedy, renamed, repayable, reserve, resolved, responder, soft, SPA, structured, succeed, successor, suggest, supported, symphony, tissue, transitioned, translate, unattractive, unavailable, unfavorable, unilaterally, unpatented, updated, worst
Valuein 2013 FY filing- Value in 2014 FY filing
Original filings
Filing view